COVID-19-from mucosal immunology to IBD patients.


Journal

Mucosal immunology
ISSN: 1935-3456
Titre abrégé: Mucosal Immunol
Pays: United States
ID NLM: 101299742

Informations de publication

Date de publication:
05 2021
Historique:
received: 04 10 2020
accepted: 05 01 2021
revised: 11 12 2020
pubmed: 21 2 2021
medline: 11 5 2021
entrez: 20 2 2021
Statut: ppublish

Résumé

Viral infections with SARS-CoV-2 can cause a multi-facetted disease, which is not only characterized by pneumonia and overwhelming systemic inflammatory immune responses, but which can also directly affect the digestive system and infect intestinal epithelial cells. Here, we review the current understanding of intestinal tropism of SARS-CoV-2 infection, its impact on mucosal function and immunology and summarize the effect of immune-suppression in patients with inflammatory bowel disease (IBD) on disease outcome of COVID-19 and discuss IBD-relevant implications for the clinical management of SARS-CoV-2 infected individuals.

Identifiants

pubmed: 33608656
doi: 10.1038/s41385-021-00384-9
pii: S1933-0219(22)00158-1
pmc: PMC7893623
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

566-573

Références

Nat Med. 2020 Sep;26(9):1428-1434
pubmed: 32661393
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2366-2368.e3
pubmed: 32437870
Gut. 2021 Apr;70(4):725-732
pubmed: 33082265
Gut. 2021 Jan;70(1):76-84
pubmed: 32732368
Nat Med. 2020 Jul;26(7):1077-1083
pubmed: 32405028
Int J Infect Dis. 2020 Jul;96:19-24
pubmed: 32311451
Cell Res. 2020 May;30(5):367-369
pubmed: 32346073
Am J Gastroenterol. 2020 Oct;115(10):1707-1715
pubmed: 32852340
Nat Commun. 2020 Jul 24;11(1):3774
pubmed: 32709909
Gastroenterology. 2021 Feb;160(3):925-928.e4
pubmed: 33075345
Gastroenterology. 2020 May;158(6):1831-1833.e3
pubmed: 32142773
Nat Med. 2020 Jun;26(6):842-844
pubmed: 32398875
Nat Immunol. 2019 Aug;20(8):970-979
pubmed: 31235952
Clin Res Hepatol Gastroenterol. 2020 Oct;44(5):e115-e120
pubmed: 32893177
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Am J Gastroenterol. 2020 Jun;115(6):916-923
pubmed: 32301761
Nature. 2020 Aug;584(7821):353-363
pubmed: 32659783
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
Cell Rep. 2020 Sep 22;32(12):108175
pubmed: 32946807
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
Immunity. 2004 Jun;20(6):769-83
pubmed: 15189741
Lancet. 2020 May 2;395(10234):1407-1409
pubmed: 32278362
Nat Rev Immunol. 2020 Oct;20(10):581-582
pubmed: 32839569
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
N Engl J Med. 2020 Dec 3;383(23):2255-2273
pubmed: 33264547
Gastroenterology. 2020 Oct;159(4):1541-1544.e2
pubmed: 32479824
Inflamm Bowel Dis. 2020 May 12;26(6):797-808
pubmed: 32333601
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Immunity. 2020 Jun 16;52(6):910-941
pubmed: 32505227
Sci Transl Med. 2021 Jan 20;13(577):
pubmed: 33288661
Nat Rev Immunol. 2020 May;20(5):271-272
pubmed: 32296135
Gastroenterology. 2020 Jul;159(1):81-95
pubmed: 32251668
Gut. 2020 Jun;69(6):997-1001
pubmed: 32241899
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
Clin Lab Med. 2014 Dec;34(4):771-85
pubmed: 25439276
Ann Intern Med. 2020 Aug 18;173(4):268-277
pubmed: 32374815
Gastroenterology. 2020 Aug;159(2):481-491.e3
pubmed: 32425234
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Gastroenterology. 2020 Oct;159(4):1575-1578.e4
pubmed: 32522507
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
N Engl J Med. 2020 Dec 10;383(24):2333-2344
pubmed: 33085857
Clin Gastroenterol Hepatol. 2021 Feb;19(2):391-393
pubmed: 33059041
Lancet. 2010 Feb 20;375(9715):657-63
pubmed: 20149425
Gastroenterology. 2003 Oct;125(4):1011-7
pubmed: 14517783
N Engl J Med. 2020 Sep 17;383(12):1191
pubmed: 32813941
Cell Stem Cell. 2020 Jul 2;27(1):125-136.e7
pubmed: 32579880
Cell. 2020 Sep 17;182(6):1419-1440.e23
pubmed: 32810438
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
Cytokine Growth Factor Rev. 2020 Jun;53:25-32
pubmed: 32446778
Gastroenterology. 2021 Jan;160(1):287-301.e20
pubmed: 32980345
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Gastroenterology. 2020 Jul;159(1):373-375.e2
pubmed: 32294477
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30
pubmed: 31648971
Science. 2020 Sep 4;369(6508):1210-1220
pubmed: 32788292
Nat Immunol. 2020 Nov;21(11):1336-1345
pubmed: 32887977
Circulation. 2020 Sep 22;142(12):1176-1189
pubmed: 32755393
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
Infection. 2021 Feb;49(1):15-28
pubmed: 32860214
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
Cell Rep Med. 2020 Oct 20;1(7):100121
pubmed: 32984855

Auteurs

Carl Weidinger (C)

Department for Medicine (Gastroenterology, Infectious diseases, Rheumatology), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.
Clinician Scientist Program, Berlin Institute of Health, Berlin, Germany.

Ahmed Nabil Hegazy (AN)

Department for Medicine (Gastroenterology, Infectious diseases, Rheumatology), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.
Clinician Scientist Program, Berlin Institute of Health, Berlin, Germany.
Deutsches Rheumaforschungszentrum Berlin (DRFZ), An Institute of the Leibniz Association, Berlin, Germany.

Rainer Glauben (R)

Department for Medicine (Gastroenterology, Infectious diseases, Rheumatology), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.

Britta Siegmund (B)

Department for Medicine (Gastroenterology, Infectious diseases, Rheumatology), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany. britta.siegmund@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH